Gut microbiota composition is associated with SARS-CoV-2 vaccine immunogenicity and adverse events

Abstract

Our study has identified specific gut microbiota markers in association with improved immune response and reduced adverse events following COVID-19 vaccines. Microbiota-targeted interventions have the potential to complement effectiveness of COVID-19 vaccines.

References

Page 1

	Year	Citations
Linking Long-Term Dietary Patterns with Gut Microbial Enterotypes Gary D. Wu, Jun Chen, Christian Hoffmann, Science NutritionDysbiosisHuman Microbial FloraMicrobiome BiologyMicrobiota Function	2011	6.4K
Safety and efficacy of the ChAdOx1 nCoV-19 vaccine (AZD1222) against SARS-CoV-2: an interim analysis of four randomised controlled trials in Brazil, South Africa, and the UK Merryn Voysey, Sue Ann Costa Clemens, Shabir A. Madhi, The Lancet	2020	5K
Neutralizing antibody levels are highly predictive of immune protection from symptomatic SARS-CoV-2 infection David S. Khoury, Deborah Cromer, Arnold Reynaldi, Nature Medicine Humoral ResponseImmunologyAntiviral ResponseHumoral ImmunityImmune Protection	2021	4.1K
Epidemiology and transmission of COVID-19 in 391 cases and 1286 of their close contacts in Shenzhen, China: a retrospective cohort study Qifang Bi, Yongsheng Wu, Shujiang Mei, The Lancet Infectious Diseases Infectious Disease EpidemiologyRetrospective Cohort StudyContact TracingVirus EpidemiologyCovid-19 Pandemic	2020	2K
Impact and effectiveness of mRNA BNT162b2 vaccine against SARS-CoV-2 infections and COVID-19 cases, hospitalisations, and deaths following a nationwide vaccination campaign in Israel: an observational study using national surveillance data Eric J. Haas, Frederick J. Angulo, John M. McLaughlin, The Lancet VaccinationVaccine SafetyNationwide Vaccination CampaignVaccine DevelopmentVaccine Surveillance	2021	1.7K
Alterations in Gut Microbiota of Patients With COVID-19 During Time of Hospitalization Tao Zuo, Fen Zhang, Grace Lui, Gastroenterology	2020	1.6K
Gut microbiota composition reflects disease severity and dysfunctional immune responses in patients with COVID-19 Yun Kit Yeoh, Tao Zuo, Grace Lui, Gut	2021	1.4K
A SARS-CoV-2 surrogate virus neutralization test based on antibody-mediated blockage of ACE2–spike protein–protein interaction Chee Wah Tan, Wan Ni Chia, Xijian Qin, Nature Biotechnology	2020	1.3K
Effectiveness of mRNA BNT162b2 COVID-19 vaccine up to 6 months in a large integrated health system in the USA: a retrospective cohort study Sara Y. Tartof, Jeff Slezak, Heidi Fischer, The Lancet VaccinationVaccine SafetyRetrospective Cohort StudyPreventive MedicineVaccine Efficacy	2021	1.3K
Immune correlates analysis of the mRNA-1273 COVID-19 vaccine efficacy clinical trial Peter B. Gilbert, David C. Montefiori, Adrian B. McDermott, Science VaccinationVaccine SafetyVaccine DevelopmentVaccine RecipientsImmunology	2022	1.2K

Page 1